Control Strategies in Pharmaceutical Drug Substance and Biologics Development and Manufacturing

Chair(s):
Marton, C., Bristol Myers Squibb
Co-chair(s):
Hannon, J., DynoChem Inc
Seibert, K. D., Eli Lilly

This session highlights the selection and monitoring of critical quality attributes (CQA) to ensure desired performance in drug substance and biologics during pharmaceutical development and/or manufacturing. The integration of empirical and theoretical process models with a control strategy is a focus of this sessions. The successes and challenges associated with advanced control strategies, such as model predictive control and multivariate control, are presented. The scope of this session includes batch, semi-continuous, and continuous processes. Academic and industrial research involving the novel use of Process Analytical Tools for on-line monitoring of CQAs are explored. Applications of lab-based PAT to identify scalable process fingerprint and establish control strategy, as well as advancements in technologies and methods toward real-time monitoring and release are included.

Papers:

Checkout

Paper abstracts are public but to access Extended Abstracts, you must first purchase the conference proceedings.

Checkout

Do you already own this?

Pricing


Individuals

AIChE Members $150.00
AIChE Emeritus Members $105.00
AIChE Graduate Student Members Free
AIChE Undergraduate Student Members Free
Non-Members $225.00